Avibactam Sodium API Market: Size, Share, Growth, Analysis, Key Players, Revenue, | Valuates Reports

Avibactam Sodium API Market
Avibactam sodium and its free acid, avibactam, are diazabicyclooctane (DBO)-based, non-β-lactam β-lactamase inhibitors (BLIs) that are used to treat multi-drug-resistant Gram-negative bacterial pathogens.
The global Avibactam Sodium API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Avibactam Sodium API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Avibactam Sodium API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Avibactam Sodium API include Cayman Chemical, ACS Dobfar SpA, Chemvon Biotechnology, Sandoo Pharmaceuticals, Jiangxi Fushine Pharmaceutical, Jingjing Pharmaceutical, Xiamen Origin Biotech and Changzhou Red Sun Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Avibactam Sodium API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avibactam Sodium API.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-20A16929/Global_Avibactam_Sodium_API_Market_Research_Report_2024

Report Scope
The Avibactam Sodium API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Avibactam Sodium API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Avibactam Sodium API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-20A16929/Global_Avibactam_Sodium_API_Market_Research_Report_2024

Segment by Type

• Purity 95%
• Purity 98%

Segment by Application

• Injections
• Oral Preparations

By Company

Cayman Chemical, ACS Dobfar SpA, Chemvon Biotechnology, Sandoo Pharmaceuticals, Jiangxi Fushine Pharmaceutical, Jingjing Pharmaceutical, Xiamen Origin Biotech, Changzhou Red Sun Pharmaceutical

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-20A16929/global-avibactam-sodium-api

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.